Browse all articles >
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma
UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma
Systemic therapy in advanced hepatocellular carcinoma2023 April;29(2)
Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma2023 April;29(2)
New next-generation microwave thermosphere ablation for small hepatocellular carcinoma2021 October;27(4)